Skip to main content
. 2020 Sep 14;6(3):00193-2020. doi: 10.1183/23120541.00193-2020

TABLE 1.

Frequency that different outcome measures were reported in 123 RCTs and 38 SRs conducted during the past decade

Outcomes Frequency of reporting
RCTs SRs
Patient important outcomes
 Mortality 101 (82%) 29 (76%)
 Treatment success or failure 77 (63%) 29 (76%)
 Adverse effects 73 (59%) 26 (68%)
 Health status, symptoms & quality of life 73 (59%) 17 (45%)
 Duration of exacerbations 42 (34%) 20 (53%)
 Re-exacerbation, re-hospitalisation 33 (27%) 16 (42%)
 Exercise capacity 14 (11%) 1 (3%)
 Anxiety and depression 6 (5%) 1 (3%)
Surrogate, physiological and laboratory outcomes
 Lung function 58 (47%) 18 (47%)
 Arterial blood gases and oxygen saturation 40 (33%) 5 (13%)
 Microbiological response 16 (13%) 7 (18%)
 Biomarkers 32 (26%) 2 (5%)
 Medication use 18 (15%) 3 (8%)

Data are presented as n (%). RCT: randomised control trial; SR: systematic review. Reproduced from [17].